Neuropsychological predictors of functional outcome in Cognitive Behavioral Social Skills Training for older people with schizophrenia

SCHIZOPHRENIA RESEARCH

卷:100

Article

Granholm, Eric^1,2  McQuaid, John R.^1,2  Link, Peter C.¹  Fish, Scott^1,3  Patterson, Thomas^1,2  Jeste, Dilip V.^1,2,4 

[1] VA San Diego Healthcare Syst, San Diego, CA 92161 USA

[2] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA

[3] SDSU UCSD, Joint Doctoral Program Clin Psychol, San Diego, CA USA

[4] Univ Calif San Diego, Dept Neurosci, San Diego, CA 92103 USA

关键词: schizophrenia;    cognitive behavior therapy;    social skills training;    neuropsychological impairment;    functioning;   

DOI  :  10.1016/j.schres.2007.11.032

来源: Elsevier

【 摘 要 】

Cognitive Behavioral Social Skills Training (CBSST) is a 24-session weekly group therapy intervention to improve functioning in people with schizophrenia. In our prior randomized clinical trial comparing treatment as usual (TAU) with TAU plus group CBSST (Granholm, E., McQuaid, JR., McClure, F.S., Auslander, L., Perivoliotis, D., Pedrelli, P., Patterson, T., Jeste, D.V., 2005. A randomized controlled trial of cognitive behavioral social skills training for middle-aged and older outpatients with chronic schizophrenia. Am. J. Psychiatry 162, 520-529.), participants with schizophrenia in CBSST showed significantly better functional outcome than participants in TAU. The present study was a secondary analysis of neuropsychological predictors of functional outcome in our prior CBSST trial. We examined (1) whether neuropsychological impairment at baseline moderated functional outcome in CBSST relative to TAU, and (2) whether improvement in neuropsychological abilities mediated improvement in functional outcome in CBSST. Attention, verbal learning/memory, speed of processing, and executive functions were assessed at baseline, end of treatment, and 12-month follow-up. Greater severity of neuropsychological impairment at baseline predicted poorer functional outcome for both treatment groups (nonspecific predictor), but the interaction between severity of neuropsychological impairment and treatment group was not significant (no moderation). Effect sizes for the difference between treatment groups on functional outcome measures at 12-month follow-up were similar for participants with relatively mild (d=.44-.64) and severe (d=.29-.60) neuropsychological impairment. Results also did not support the hypothesis that improvement in neuropsychological abilities mediated improvement in functioning in CBSST. Adding CBSST to standard pharmacologic care, therefore, improved functioning relative to standard care alone, even for participants with severe neuropsychological impairment, and this improvement in functioning was not related to improvement in neuropsychological abilities in CBSST. Published by Elsevier B.V.

【 授权许可】

Free